('hlorothiazide decreases plasma volume, heart size, and cardiac output. The oligeamii stimulates vasomotor tone; this tends to maintain arterial pressure because chronic arterial hypertension is characteristically self-sustaining and homeostatic. This oligenmic stimulation of vasomotor tone results in increased sensitivity to the antihypertensivQe effect of drugs depressing or blocking vasomotor function.
APRELIMINARY report,' oii chlorothia-24, zide-induced sensitizatiomn to the hypotensive effect of antihypertensive ganglioplegic drugs, described an association between the sensitization and reduction of plasma volume, and suggested that this depletion might be the primary mechanism. Other possible mechanisms were not excluded.
Iln the previous study we had anticipated that the depressor response to " bloodless phlebotomy " would be intensified during (hlorothiazide treatment. Such all intensification was not found, and this seemed inconsistent with the concept of oligemia as the primary mechanism. However, Dr. James MeCubbin, of this Division, suggested that the seeming paradox might be explained by illcrease in vasomotor activity that occurs during oligemia2' 3 and, further, that increased vasomotor tone would also account for the enhanced responsiveness to ganglioplegic drugs such as occurs in the neurogenic hypertensive dog. 4 This report describes experiments in which this concept was tested by indirect methods. The results are consistent with the concept.
METHODS
The effects of chlorothiazide on cardiac output, blood pressure, and total peripheral resistance were studied in 11 hospitalized hypertensive patients. The effects of "prolonged" administration were From the Research Division, Cleveland Clinic Foundation, Frank E. Bunts Educational Institute, Cleveland, Ohio. Supported in part by a grant (H-96) from the National Heart Institute. 360 studied in 9 patients who received 1 Gmii. of chlorothiazide? twice daily for periods ranlgini, fromn 4 to 6 days, and effects of intravenous administration were studied in 2 patients who were given 500 mg. In the prolonged study, hemnodynaie measurements were made before and at the end of the period of drug treatment, except in 3 patients in whom the sequence of observations was reversed. In the 2 patients who were studied after intravenous administration, miieasuremiients were made immediately before and 1 hour after the injection. One patient continued to take 200 iii.g. of hydralazine daily; the remaining patients received no vasoactive drugs during the period of ehl)rotlhiazide administration. To investigate further the enhanced responsiveness to ganglioplegie drugs induced by chlorothiazide, 7 patients were given tetraethvlammiiiionium chloride (TEAC) intravenously inniediately after the control and "drug" observations had been made. Each patient received 5 img./Kg. at a rate of 1 imig0./Kg./inia.; 5 and 15 minutes after the injection, cardiac output and blood pressure measurements were repeated. The effects of an infusion of 500 ml. of dextra n were studied in 1 who was not given TEA C.
Throughout the period of investigation blood pressure was measured 4 times daily in the supine and standing positions. In addition, heart size was determined in 12 patients fromn teleroentgeno-,grams during both the control and "drug" periods. Six of these patients were from this study group.
The remaining 6 Infusion of Dextran. To explore the possibility that decreases in cardiac output during chlorothiazide administration were due to hypovolemia, 1 patient, who had been given chlorothiazide for 6 days and had sustained a 16 per cent decrease in cardiac output, was given 500 ml. of dextran intravenously ( fig.  2 ). This infusion was started immediately after the determination of cardiac output; it was given at a rate of 15 ml./min.; output measurements were repeated after 300 ml. and 500 ml. of dextran had been given. The initial infusion of dextran increased blood pressure and cardiac output and decreased Sodium Loss as a Possible Prinmary Mechanssm. Chlorothiazide causes a depletion of both sodium and water, and these effects are not easily separated. Sodium depletion might be antihypertensive by its effect on blood volume or, hypothetically, by withdrawing salt and water from the walls of arteries and arterioles. That the effect of chlorothiazide depends primarily on volume rather than oil some action of the sodium ion is suggested by the one observation in which salt-free dextran restored cardiac output and arterial pressure during chlorothiazide-induced oligemia. As concerns the possible effects of "dehydration" of vessel walls, it should be noted that, with the exception of one patient, total peripheral resistance increased and did not decrease during treatment with chlorothiazide. This process is also exemplified inl the dog with renal hypertension, in which, with the course of time, the buffer nerves "re-set" so that this system ultimately tends to maintaini, by a neurogenie mechanism, a hypertension that was primarily renal.ts The action of (hlorothiazide in hypertension is still another case in point. Here, however, therapeutic advantage is taken of this interesting natural phenomenon. The sequence, iii most patients, is that chlorothiazide decreases plasma volume amid thus tends to decrease arterial pressure. The "hoineostasis" of hypertension then results in increased vasomotor tone, tending to sustain pressure. At this point the administration of an agemit which diminishes vasomotor tone reduces arterial pressure more effectively than it would in the absence of increased vasomotor tone.
SUMMARY AND CONCLUSIONS Chlorothiazide, orally administered to hypertensive patients over the course of a few days, decreases plasma volume, heart size, cardiac output, and increases total peripheral resistance in most, and also sensitivity to the depressor effect of intravenously injected TEAC, without affecting the depressant effect of TEAC on cardiac output.
The data are consistent with the view that the primary mechanism by which chlorothiazide enhances responsiveness to the anitihypertensive effects of drugs acting on the vasomotor system is that it causes oligemnia which evokes intensification of vasomnotor tonie. This increases the fraction of the hypertension which is sustained by the vasomotor system, establishing a degree of neurogenic hypertension, which is susceptible to relief by such drugs.
SUMMARIO IN INTERLINGUA
Chlorothiazido, quando administrate per via oral a patientes hypertensive durante un curso de plure dies, reduce le volumine del plasma, le dimensiones del corde, e le rendiinento cardiac e augmenta-in le majoritate del casos-le total resistentia peripheric e le sensibilitate al effecto depressori de chloruro de tetraethylammonium, sed illo non affice le effecto depressori de chloruro de tetraethylammonium super le rendimento cardiac.
Iste datos es compatibile con le concepto que le mechanismo primari per que chlorothiazido promove le responsivitate al potential antihypertensive de drogas que age super le systema vasomotori consiste in le facto que illo eausa oligemia le qual, de su parte, evoca un intensification del tono vasomotori. Isto augmenta le parte del hypertension que es sustenite per le systema vasomotori e establi un grado de hypertension neurogene que es susceptibile de esser alleviate per tal drogas.
